Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
in vitro fertilization
Biotech
ObsEva gets China rights to pregnancy drug over missed deadline
ObsEva has resecured the China rights to its pregnancy drug after Yuyuan BioScience allegedly failed to hit pre-agreed milestones on time.
James Waldron
Jul 13, 2023 7:50am
Sumitomo inks Myovant $2.9B buyout, adding IVF asset to pipeline
Oct 24, 2022 7:00am
NIH-backed research turns out rapid embryo screening test
Aug 18, 2022 11:06am
Fairtility welcomes EU approval for embryo assessment AI
Jul 5, 2022 3:32pm
Fujifilm picks up AI program for IVF procedures
Jun 24, 2022 11:38am
